Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Phreesia is a health information services business based in the US. Phreesia shares (PHR) are listed on the NYSE and all prices are listed in US Dollars. Phreesia employs 1,701 staff and has a trailing 12-month revenue of around $262.3 million.
Finder Award
SoFi Invest
Finder Award
eToro
Robinhood
| Latest market close | $37.22 |
|---|---|
| 52-week range | $13.19 - $38.13 |
| 50-day moving average | $31.77 |
| 200-day moving average | $25.55 |
| Wall St. target price | $37.57 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-3.08 |
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $37.22 from 2023-02-01
| 1 week (2023-01-25) | 6.49% |
|---|---|
| 1 month (2022-12-30) | 15.02% |
| 3 months (2022-10-29) | N/A |
| 6 months (2022-08-02) | 50.69% |
| 1 year (2022-02-02) | 20.49% |
|---|---|
| 2 years (2021-02-02) | -46.01% |
| 3 years (2020-01-31) | 20.06% |
| 5 years (2018-01-29) | N/A |
| Revenue TTM | $262.3 million |
|---|---|
| Gross profit TTM | $131.8 million |
| Return on assets TTM | -24.71% |
| Return on equity TTM | -47.43% |
| Profit margin | -70.36% |
| Book value | $6.08 |
| Market capitalisation | $2 billion |
TTM: trailing 12 months
We're not expecting Phreesia to pay a dividend over the next 12 months.
Over the last 12 months, Phreesia's shares have ranged in value from as little as $13.19 up to $38.13. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Phreesia's is 0.6018. This would suggest that Phreesia's shares are less volatile than average (for this exchange).
Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. Its Phreesia Platform offers a suite of solutions to manage the patient intake process, as well as an integrated payments solution for processing of patient payments. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, which are self-service intake tablets; and Arrivals Kiosks that are on-site kiosks. Its Phreesia Platform also provides a registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, and cost estimation tools; access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking; and life sciences solution to deliver targeted and clinically relevant marketing content to patients. In addition, the company's Phreesia Platform offers clinical support solution, which collects clinical intake and patient reported outcome (PRO) data for approximately 25 specialties, as well as enables healthcare services clients to communicate with their patients through surveys, announcements, text and email messaging, and health campaigns; and COVID-19 support modules for managing COVID-19 vaccine delivery and identify vaccine-hesitant patients, screening for self-reported COVID-19 risk factors, enabling contactless check-in during in-person visits, and collecting intake information during telehealth visits. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies.
Everything we know about the TXO Energy IPO, plus information on how to buy in.
Everything we know about the Brera IPO, plus information on how to buy in.
What you need to know about investing in the leading indicator for the overall US stock market.
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
Your simple and straightforward guide to ETFs, how they work and the different types available.
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
Everything we know about the SONDORS IPO, plus information on how to buy in.
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
Learn about stock analysis and how to use it to find the right company to buy.
